Oncology Live CME - Webinar Series

Oncology Live CME - WEBINAR SERIES
2nd Wednesday of Every Month - Virtual

Strategies for diagnosis and management of patients with hematologic and solid tumor malignancies are rapidly expanding. Delivering state of the art, evidence-based care requires ongoing continuing medical education. To meet the educational needs of practicing oncology specialists, UC San Diego is launching a disease specific monthly CME seminar series focused on providing clinicians with up-to-date and evidence-based data on evolving oncology practices. As the volume of clinical data exponentially grows, our goal is to deliver real-time, practical data to optimize the diagnosis and treatment of patients with oncologic conditions. This virtual CME series will feature talks by invited guest faculty and UC San Diego faculty, all with internationally or nationally renowned expertise in the field of their presentation, as well as interactive case-base discussions with our guests and local experts.

Learning objectives, target audience, and accreditation vary per webinar. Please see individual courses on the schedule tab.

REGISTRATION IS FREE!

Registration must be completed prior to the webinar start time. CME credit will only be awarded to those that register and attend the course. 

Follow the Conversation at #OncologyLiveCME

Resources (Past Webinars)

July 17, 2024 - Molecular Sequencing and Novel Therapeutics in Pancreatic Cancer - Gregory Botta, MD, PhD & Diane Simeone, MD

Drs. Simeone and Botta will discuss germline/blood/tumor tissue next generation sequencing in pancreatic cancer. They will discuss how clinicians should incorporate this information into their clinical practice and to find clinical trials. They will cover the use of ctDNA in clinical decision making during the perioperative and surveillance periods. 

Emails: [email protected] / [email protected]
Botta Presentation Slides
Simeone Presentation Slides
Video

 June 12, 2024 - Treatment of Hepatocellular Carcinoma: A Multi-Disciplinary Approach - Zachary Berman, MD, Adam Burgoyne, MD, PhD & Yuko Kono, MD, PhD

Recent advances in therapeutic options for hepatocellular carcinoma have challenged prior paradigms for treatment. We will discuss how surgical resection and liver transplant, locoregional therapies, and systemic therapies are used in current clinical practice and how they are interfacing in the future with a multimodal approach.

Emails: [email protected] / [email protected] / [email protected]
Berman Presentation Slides
Burgoyne Presentation Slides
Kono Presentation Slides
Video

May 8, 2024 - Recent Changes in Melanoma Management: Neoadjuvant, Brain Metastasis and Systemic Therapies - Gregory A. Daniels, MD, PhD, 
Joel M. Baumgartner, MD, MAS, FACS & Parag Sanghvi, MD, MSPH

This course will focus on significant updates in the care for melanoma patients. Presentations will cover appropriate use of neoadjuvant therapy integrating surgery and medical oncology. The use of radiation continues to be critical for management of brain metastasis but needs to be balanced with available systemic therapies. Lastly, new systemic treatment options including cell therapy and new immune checkpoints will be reviewed in a multidisciplinary case-based discussion.

Emails: [email protected]/ [email protected] / [email protected]
Daniels Presentation Slides
Baumgartner Presentation Slides
Sanghvi Presentation Slides
Video

April 10, 2024 - Innovative Care for Head and Neck Cancer: A 2024 Update of Changing Paradigms - Joseph Califano, MD, Loren K. Mell, MD, FASTRO & 
Assuntina G. Sacco, MD

This course will provide an overview of current and emerging therapies for head and neck cancers, including new treatment paradigms incorporating immunotherapy as well as new treatment standards for radiation therapy and surgical treatment. This will include specific discussion of integration and sequencing of therapies in a multidisciplinary care model.

Emails: [email protected] / [email protected] / [email protected]
Califano Presentation Slides
Mell Presentation Slides
Sacco Presentation Slides
Video

March 20, 2024 - Total Neoadjuvant Therapy in Rectal Cancer - Gregory Botta, MD, PhD & Christopher Straka, MD, DABR

This course will focus on the protocolization and process of rectal cancer patients through a multi-disciplinary cancer team for best response.   

Emails: [email protected] / [email protected]
Straka Presentation Slides
Video

February 28, 2024 - Optimizing Treatment Outcomes in Testicular Cancer Patients and Young Adult Survivorship - Aditya Bagrodia, MD, FACS, Fred Millard, MD & Jessica Schulte, MD, PhD

This course will focus on state-of-the-art management of early stage and advanced testicular cancer. Specific focus will be provided toward minimizing treatment-related morbidity.  We will review current and future diagnostics, surgical treatment, systemic treatment strategies, and survivorship. The course will include multidisciplinary lectures from urology, medical oncology, and survivorship oncology with a practical panel discussion in clinical management options for patients. 

Emails: [email protected]/ [email protected] / [email protected]
Bagrodia Presentation Slides
Millard Presentation Slides
Schulte Presentation Slides
Video

January 17, 2024 - Therapeutic Advances in the Management of Gynecologic Malignancies - Pratibha Binder, MD & Dominique Rash, MD, FACRO

This course will highlight the recent advances across multiple disciplines (surgery, radiation and systemic therapy) that have had a substantial impact on cancer outcomes among patients with cervical and endometrial cancer.   

Emails: [email protected] & [email protected]
Binder Presentation Slides
Rash Presentation Slides
Video

November 8, 2023 -  Updates in Multidisciplinary Management of Lung Cancer - Lyudmila A. Bazhenova, MD, Mark W. Onaitis, MD & James J. Urbanic, MD

This course will provide updates in the multidisciplinary management of lung cancer. Topics discussed will include: Biomarkers in Lung Cancer: state of the art; minimally-invasive surgery for lung cancer & radiation and proton therapy for lung cancer.  

Emails: [email protected] / [email protected] / [email protected]
Bazhenova Presentation Slides
Onaitis Presentation Slides
Urbanic Presentation Slides
Video

October 11, 2023 -  Updates in Multidisciplinary Management of Breast Cancer - Julie Le, MD, Gina Mansy, MD, FACRO & Jennifer Matro, MD

This course will provide updates in the multidisciplinary management of breast cancer including systemic treatment, surgical and novel approaches in breast radiotherapy.  

Emails: [email protected] / [email protected] / [email protected]
Le Presentation Slides
Mansy Presentation Slides
Matro Presentation Slides
Video

September 13, 2023 -  Integrated Multidisciplinary Treatment for Patients with Advanced Prostate Cancer - Aditya Bagrodia, MD, FACS, Rana R. McKay, MD & 
Brent Rose, MD

This course will focus on the multidisciplinary management of advanced prostate cancer covering diagnostics, surgical treatment, radiation therapy, and systemic treatment strategies. The course will include multidisciplinary lectures from urology, radiation oncology, and medical oncology with a practical panel discussion in clinical management options for patients.  

Emails: [email protected] / [email protected] / [email protected]
Bagrodia & Rose Presentation Slides
McKay Presentation Slides
Video

1. Review current risk factors and screening techniques for solid tumor and hematologic cancers.
2. Examine state of the art treatment options for solid tumor and hematologic cancer.
3. Assess strategies to diagnosis and treat side effects related to the disease or treatment .
4. Compare strategies to optimize quality of life and survivorship for patients.
5. Evaluate patient outcomes using new prevention, diagnosis, and treatment options, relative to the current standard of care.

AAPA: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.00 hours of Category 1 credit for completing this program.

Nurses: For the purpose of recertification, the American Nurses Credentialing Center accepts AMA PRA Category 1 Credits™ issued by organizations accredited by the ACCME. For the purpose of relicensure, the California Board of Registered Nursing accepts AMA PRA Category 1 Credits™ (report up to 1.00 hours of credit and list "CME Category 1" as the provider number).

Pharmacists: The California Board of Pharmacy accepts as continuing education for pharmacists coursework which meets the standard of relevance to pharmacy practice and is accepted as continuing education by the Medical Board of California.

Surgeons: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

All persons in a position to control the content of accredited education must disclose all financial relationships held with ineligible companies, prior to assuming their role in the accredited activity. Those relationships deemed relevant to the education, are mitigated prior to the activity.

CME staff, meeting planners, peer reviewers, editorial staff, and CME committee reviewers, do not have any relevant financial relationships with ACCME-defined ineligible companies.

Mitigation of Relevant Financial Relationships

The UC San Diego School of Medicine adheres to the ACCME Standards for Integrity and Independence in Accredited Continuing Education. 

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Rana McKay, MD
Associate Professor of Medicine and Urology
UC San Diego
La Jolla, CA

Course Director

Consulting Fee-Aveo|Consulting Fee-Bayer (Any division)|Consulting Fee-Bristol-Myers Squibb Company|Consulting Fee-Calithera (Relationship has ended)|Consulting Fee-Caris |Consulting Fee-Dendreon (Relationship has ended)|Consulting Fee-Exelixis, Inc.|Consulting Fee-Janssen (Any division) (Relationship has ended)|Consulting Fee-Eli Lilly|Consulting Fee-Merck (Any division)|Consulting Fee-Myovant|Consulting Fee-Pfizer (Any division)|Consulting Fee-Novartis Corporation Pharmaceuticals|Consulting Fee-Sanofi S.A.|Consulting Fee-Sorrento Theraeutics|Consulting Fee-Seattle Genetics, Inc.|Consulting Fee-Telix|Consulting Fee-Tempus|Grant or research support-Tempus|Grant or research support-Bayer (Any division)|Grant or research support-Oncternal|Grant or research support-AstraZeneca (Any division)|Grant or research support-Exelixis, Inc.|Consulting Fee-AstraZeneca (Any division)

Dominique Rash, MD
Associate Professor of Radiation Medicine and Applied Sciences
UC San Diego
La Jolla, CA

Course Director

Nothing to disclose

Contact Us 
UC San Diego School of Medicine
Continuing Professional Development
9500 Gilman Drive, MC0947
La Jolla, CA 92093-0947 
Phone: (858) 534-3940 or (888) 229-6263 
Fax: (858) 534-1896 
E-mail: cpdoffice@health.ucsd.edu
Website: cpd.ucsd.edu